Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)
Michele Marchioni, Maximilian C. Kriegmair, Mathias Heck, Thomas Amiel, Francesco Porpiglia, Enrico Ceccucci, Riccardo Campi, Andrea Minervini, Andrea Mari, Siska Van Bruwaene, Estefanía Linares, Vital Hevia, Mireía Musquera, Mauricio D’Anna, Ithaar Derweesh, Aaron Bradshaw, Riccardo Autorino, Georgi Guruli, Alessandro Veccia, Eduard Roussel, Maarten Albersen, Nicola Pavan, Francesco Claps, Alessandro Antonelli, Carlotta Palumbo, Tobias Klatte, Selçuk Erdem, Maria Carmen Mir
Topics & Concepts
MedicineInterquartile rangeRenal cell carcinomaHazard ratioProportional hazards modelConcordanceNephrectomyInternal medicinePerformance statusCancerUrologySurgeryOncologyConfidence intervalKidneyRenal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsMultiple and Secondary Primary Cancers